Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Horizon Therapeutics Public Ltd Co changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 6 | 1 | −5 |
| Shares | 426 | 1 | −425 (−99.8%) |
| Value | $49.4K | $116 | −$49.3K (−99.8%) |
New holders (0)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q1 2024 but not at the end of Q4 2023.
None.
Sold out (5)
Institutions that held Horizon Therapeutics Public Ltd Co at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| IFP Advisors, Inc | 332 | $38.4K |
| Ronald Blue Trust, Inc. | 42 | $5.00K |
| Valued Wealth Advisors LLC | 28 | $3.24K |
| Financial Synergies Wealth Advisors, Inc. | 13 | $1.48K |
| Beacon Capital Management, LLC | 10 | $1.16K |